Apotex, Others Ask Fed. Circ. To Nix Allergan Latisse Patents
Apotex Inc. and two other generic-drug makers pushed a Federal Circuit panel Wednesday to invalidate two Allergan Inc. patents for the eyelash growth stimulant Latisse and lift a permanent injunction against...To view the full article, register now.
Already a subscriber? Click here to view full article